Search academic texts

Information × Registration Number 0219U001636, 0117U000576 , R & D reports Title Creation of a pharmaceutical preparation based on interferon and nanoparticles of cerium dioxide and its preclinical studies popup.stage_title Head Oksamytnyi Viktor Mykolajovych, Registration Date 13-02-2019 Organization 3.State Center of Innovation Biotechnologies popup.description2 The purpose of the work is to develop a complex drug based on interferon and nanoparticles of cerium dioxide and to conduct its preclinical research. Methods of research - physico-chemical, microbiological, virological, biochemical, microscopic, morphological, biotechnological, pharmacological. In 2018, preclinical studies of nanobiocomposite based on recombinant human interferon and cerium dioxide nanoparticles were continued. In particular, the mutagenic action of the nanobiocomposite developed using a micronucleus test on polychromatophilic erythrocytes of mice was studied. The obtained results can be considered as evidence of the prospect of using nanobiocomposite based on interferon and cerium dioxide nanoparticles as an antitumor preparation. Product Description popup.authors Оксамитний Віктор Миколайович Синицин Віталій Анатолійович popup.nrat_date 2020-04-02 Close